Screening of the optimized prescription from Suqingwan in terms of its therapeutic effect on DSS-induced ulcerative colitis by its regulation of inflammatory and oxidative mediators
Keywords: UC; ulcerative colitis; TCMs; traditional Chinese medicines; SQW; Suqingwan; DSS; dextran sulfate sodium; SPs; separated prescriptions; SP1-9; separated prescription 1-9; DAI; disease activity index; CP; calculated prescription; MPO; myeloperoxidase; MD